Ginkgo Bioworks Holdings (DNA) Tax Rate Growth (3y) (2023 - 2026)

Ginkgo Bioworks Holdings (DNA) Tax Rate Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn -
4 BeOne Medicines 470.64 Bn 465.84 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.91 Bn 115.67 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn
7 Belite Bio 62.77 Bn 62.77 Bn -
8 Argenx Se 56.21 Bn 51.02 Bn 1.41 Bn
9 Revolution Medicines 37.60 Bn 37.60 Bn -
10 Ginkgo Bioworks Holdings 446.73 Mn 302.86 Mn 16.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.00
Dec 31, 2025 -707.00
Sep 30, 2025 -1.00
Jun 30, 2025 46.00
Mar 31, 2025 -14.00
Dec 31, 2024 26.00
Sep 30, 2024 46.00
Jun 30, 2024 -87.00
Mar 31, 2024 -23.00
Dec 31, 2023 -391.00
Sep 30, 2023 3.00